Logo image of IMD.MI

IMD INTERNATIONAL MEDICAL DE (IMD.MI) Stock Fundamental Analysis

Europe - BIT:IMD - IT0005549255 - Common Stock

1.44 EUR
-0.09 (-5.88%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to IMD. IMD was compared to 59 industry peers in the Health Care Equipment & Supplies industry. While IMD has a great health rating, its profitability is only average at the moment. IMD may be a bit undervalued, certainly considering the very reasonable score on growth IMD also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year IMD was profitable.
IMD had a positive operating cash flow in the past year.
IMD.MI Yearly Net Income VS EBIT VS OCF VS FCFIMD.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M -4M 6M 8M

1.2 Ratios

IMD has a better Return On Assets (9.99%) than 86.44% of its industry peers.
IMD has a better Return On Equity (15.32%) than 81.36% of its industry peers.
IMD's Return On Invested Capital of 13.33% is amongst the best of the industry. IMD outperforms 91.53% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IMD is above the industry average of 8.90%.
The last Return On Invested Capital (13.33%) for IMD is above the 3 year average (12.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.99%
ROE 15.32%
ROIC 13.33%
ROA(3y)7.1%
ROA(5y)N/A
ROE(3y)13.65%
ROE(5y)N/A
ROIC(3y)12.28%
ROIC(5y)N/A
IMD.MI Yearly ROA, ROE, ROICIMD.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30

1.3 Margins

IMD has a Profit Margin of 6.04%. This is comparable to the rest of the industry: IMD outperforms 52.54% of its industry peers.
IMD's Profit Margin has declined in the last couple of years.
IMD's Operating Margin of 8.44% is in line compared to the rest of the industry. IMD outperforms 49.15% of its industry peers.
IMD's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 26.82%, IMD is not doing good in the industry: 83.05% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of IMD has declined.
Industry RankSector Rank
OM 8.44%
PM (TTM) 6.04%
GM 26.82%
OM growth 3Y-15.05%
OM growth 5YN/A
PM growth 3Y-13.98%
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5YN/A
IMD.MI Yearly Profit, Operating, Gross MarginsIMD.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20 25

More info and screens

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IMD is creating some value.
Compared to 1 year ago, IMD has about the same amount of shares outstanding.
The debt/assets ratio for IMD has been reduced compared to a year ago.
IMD.MI Yearly Shares OutstandingIMD.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
IMD.MI Yearly Total Debt VS Total AssetsIMD.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

IMD has an Altman-Z score of 4.70. This indicates that IMD is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 4.70, IMD belongs to the best of the industry, outperforming 84.75% of the companies in the same industry.
The Debt to FCF ratio of IMD is 0.07, which is an excellent value as it means it would take IMD, only 0.07 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.07, IMD belongs to the best of the industry, outperforming 98.31% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that IMD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, IMD belongs to the top of the industry, outperforming 94.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.07
Altman-Z 4.7
ROIC/WACC1.68
WACC7.95%
IMD.MI Yearly LT Debt VS Equity VS FCFIMD.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

IMD has a Current Ratio of 3.27. This indicates that IMD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IMD (3.27) is better than 89.83% of its industry peers.
A Quick Ratio of 1.88 indicates that IMD should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.88, IMD is doing good in the industry, outperforming 77.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 1.88
IMD.MI Yearly Current Assets VS Current LiabilitesIMD.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

IMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.64%, which is quite impressive.
The earnings per share for IMD have been decreasing by -17.97% on average. This is quite bad
IMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 55.60%.
The Revenue has been decreasing by -5.22% on average over the past years.
EPS 1Y (TTM)60.64%
EPS 3Y-17.97%
EPS 5YN/A
EPS Q2Q%77.03%
Revenue 1Y (TTM)55.6%
Revenue growth 3Y-5.22%
Revenue growth 5YN/A
Sales Q2Q%111.04%

3.2 Future

IMD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.27% yearly.
Based on estimates for the next years, IMD will show a small growth in Revenue. The Revenue will grow by 1.81% on average per year.
EPS Next Y-23.53%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
EPS Next 5YN/A
Revenue Next Year0.61%
Revenue Next 2Y1.52%
Revenue Next 3Y1.81%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IMD.MI Yearly Revenue VS EstimatesIMD.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
IMD.MI Yearly EPS VS EstimatesIMD.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.05 0.1 0.15 0.2

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

IMD is valuated cheaply with a Price/Earnings ratio of 6.86.
Based on the Price/Earnings ratio, IMD is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of IMD to the average of the S&P500 Index (27.20), we can say IMD is valued rather cheaply.
A Price/Forward Earnings ratio of 10.97 indicates a reasonable valuation of IMD.
IMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. IMD is cheaper than 89.83% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, IMD is valued rather cheaply.
Industry RankSector Rank
PE 6.86
Fwd PE 10.97
IMD.MI Price Earnings VS Forward Price EarningsIMD.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

IMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IMD is cheaper than 94.92% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IMD is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.43
EV/EBITDA 3.14
IMD.MI Per share dataIMD.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as IMD's earnings are expected to decrease with -6.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%

More info and screens

7

5. Dividend

5.1 Amount

IMD has a Yearly Dividend Yield of 7.14%, which is a nice return.
Compared to an average industry Dividend Yield of 2.30, IMD pays a better dividend. On top of this IMD pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, IMD pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.14%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

31.48% of the earnings are spent on dividend by IMD. This is a low number and sustainable payout ratio.
DP31.48%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
IMD.MI Yearly Income VS Free CF VS DividendIMD.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 2M -2M 4M -4M 6M
IMD.MI Dividend Payout.IMD.MI Dividend Payout, showing the Payout Ratio.IMD.MI Dividend Payout.PayoutRetained Earnings

More info and screens

IMD INTERNATIONAL MEDICAL DE

BIT:IMD (9/12/2025, 7:00:00 PM)

1.44

-0.09 (-5.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.93%
Inst Owner ChangeN/A
Ins Owners75.51%
Ins Owner ChangeN/A
Market Cap25.42M
Analysts45.71
Price Target2.03 (40.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.14%
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP31.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-56.67%
EPS NY rev (3m)-56.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.58%
Valuation
Industry RankSector Rank
PE 6.86
Fwd PE 10.97
P/S 0.43
P/FCF 3.43
P/OCF 3.16
P/B 1.09
P/tB 1.16
EV/EBITDA 3.14
EPS(TTM)0.21
EY14.58%
EPS(NY)0.13
Fwd EY9.12%
FCF(TTM)0.42
FCFY29.14%
OCF(TTM)0.46
OCFY31.68%
SpS3.35
BVpS1.32
TBVpS1.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.99%
ROE 15.32%
ROCE 19.44%
ROIC 13.33%
ROICexc 19.72%
ROICexgc 21.42%
OM 8.44%
PM (TTM) 6.04%
GM 26.82%
FCFM 12.52%
ROA(3y)7.1%
ROA(5y)N/A
ROE(3y)13.65%
ROE(5y)N/A
ROIC(3y)12.28%
ROIC(5y)N/A
ROICexc(3y)15.57%
ROICexc(5y)N/A
ROICexgc(3y)16.37%
ROICexgc(5y)N/A
ROCE(3y)17.89%
ROCE(5y)N/A
ROICexcg growth 3Y-23.19%
ROICexcg growth 5YN/A
ROICexc growth 3Y-24.4%
ROICexc growth 5YN/A
OM growth 3Y-15.05%
OM growth 5YN/A
PM growth 3Y-13.98%
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5YN/A
F-Score6
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.07
Debt/EBITDA 0.06
Cap/Depr 106.95%
Cap/Sales 1.09%
Interest Coverage 250
Cash Conversion 143.92%
Profit Quality 207.4%
Current Ratio 3.27
Quick Ratio 1.88
Altman-Z 4.7
F-Score6
WACC7.95%
ROIC/WACC1.68
Cap/Depr(3y)149.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.64%
EPS 3Y-17.97%
EPS 5YN/A
EPS Q2Q%77.03%
EPS Next Y-23.53%
EPS Next 2Y-9.25%
EPS Next 3Y-6.27%
EPS Next 5YN/A
Revenue 1Y (TTM)55.6%
Revenue growth 3Y-5.22%
Revenue growth 5YN/A
Sales Q2Q%111.04%
Revenue Next Year0.61%
Revenue Next 2Y1.52%
Revenue Next 3Y1.81%
Revenue Next 5YN/A
EBIT growth 1Y40.38%
EBIT growth 3Y-19.48%
EBIT growth 5YN/A
EBIT Next Year63.84%
EBIT Next 3Y-0.68%
EBIT Next 5YN/A
FCF growth 1Y354.49%
FCF growth 3Y32.27%
FCF growth 5YN/A
OCF growth 1Y712.77%
OCF growth 3Y35.57%
OCF growth 5YN/A